[News] Filling the gap in the treatment of differentiated thyroid cancer in China - Human thyrotropin injection approved for marketing

On April 11, according to the announcement of the State Food and Drug Administration, human thyroid-stimulating hormone injection (generic celebrity thyroid-stimulating hormone injection, trade name Zhishujia?) was approved for marketing, and the indication is for the adjuvant treatment of iodine [131I] to remove residual thyroid tissue in patients with differentiated thyroid cancer without distant metastasis after total thyroidectomy or near-total thyroidectomy.

[Live replay] 2023 Nuclear Medicine Molecular Imaging New Technology Exchange Conference of the Nuclear Medicine Equipment and Technology Professional Committee of the China Medical Equipment Associat

2024 Annual Meeting of Nuclear Medicine Equipment and Technology Professional Committee of China Association of Medical Equipment

Proposal for the 2024 Two Sessions: Member Li Sijin: Proposal on Avoiding Excessive Medical Care and Effectively Saving Medical Insurance Expenditures

The number of patients with coronary heart disease in China is 11.39 million, and its incidence rate and mortality rate are increasing year by year. The annual medical expenditure is more than 100 billion yuan.

Hot spots of the two sessions | Member Li Sijin: Proposal on strengthening the scientific management of nuclear drugs (radiopharmaceuticals) to benefit the majority of patients

Nuclear medicine is an important part of modern medicine, and it plays an irreplaceable role in the early and accurate diagnosis, treatment, efficacy monitoring and individualized treatment of diseases, especially major diseases such as tumors, cardiovascular and central nervous system diseases.

First clinical application of a novel PSMA targeted tracer [18F] AlF-P16-093

Prostate cancer, as the second most common cancer in men, has always been a key research area in the medical community for its diagnosis and treatment.

The National Nuclear Medicine High-quality Development and talent Training Pilot Project Launch Meeting was held with the academic support of the Chinese Nuclear Medicine Branch

On December 3, 2023, the kick-off meeting of the "National Pilot Project for High-quality Development and Talent Training of Nuclear Medicine", jointly sponsored by the Talent Exchange Service Center of the National Health Commission and the China Primary Health Care Foundation, and supported by the Nuclear Medicine Branch of the Chinese Medical Association, was successfully held in Beijing.

| The third offline practical training course for Medical Physicists (Nuclear Medicine) was successfully held

From December 1 to 3, 2023, sponsored by the Nuclear Medicine Branch of the Chinese National Health Association and the Training Department of the Chinese National Health Association, repair and Jiaxing First Hospital undertook, and the Chinese Medical Association Nuclear Medicine Branch as a technical support unit of the third period of medical physicists (nuclear medicine) offline practical training course was successfully held in Jiaxing, Zhejiang

The East Asia Nuclear Medicine Joint Academic Conference and the China-Japan Nuclear Medicine Exchange Association working Conference were grandly opened in Osaka, Japan

On November 17, 2023, the 3rd East Asian Nuclear Medicine Joint Academic Conference, the 18th China-Japan Nuclear Medicine Exchange Association Working Conference and the 63rd Annual Conference of the Japan Nuclear Medicine Association and the 43rd Annual Conference of the Japan Nuclear Medicine Technology Society were grandly opened in Osaka, Japan.

【 Wind of Daxing Investigation and research 】 Leaders and experts from the Ministry of Ecology and Environment visited the Nuclear medicine Department of Wuhan Union Hospital for investigation

[Editor's note] The development of nuclear medicine has been troubled by too much, among which the relevant standards of radiation protection in nuclear medicine have attracted much attention and heated discussion. On September 11, 2023, we received a reply from the Ministry of Ecology and Environment to the Chinese Society for Radiation Protection's "Request for Consultation on relevant Provisions of Nuclear Medicine Standards"

[Sichuan] Sichuan Provincial Health Commission investigated the development of nuclear medicine in Sichuan

On June 24, 2021, the China Atomic Energy Authority, the Ministry of Science and Technology and other eight departments officially issued the Medium and Long Term Development Plan for Medical Isotopes (2021-2035)

Unprecedented spectacle, precise focus; Wonderful event, expansion and innovation - The 2023 Academic Annual meeting of the Nuclear Medicine Branch of the Chinese Medical Association was held in Xi an

The 2023 Annual Conference of the Nuclear Medicine Branch of the Chinese Medical Association was held in Xi 'an, Shaanxi Province from September 21 to 23, 2023. The opening ceremony was presided over by the standing member of the Nuclear Medicine Branch of the Chinese Medical Association, Professor LAN Xiaoli of the Nuclear Medicine Department of Wuhan Union Medical College Hospital

The 15th Congress of the Asian-Oceanian Union for Nuclear Medicine and Biology (AOCNMB 2023) has opened in Amman, Jordan（AOCNMB 2023）

On October 5, 2023, the 15th Congress of the Asian-Oceanian Union for Nuclear Medicine and Biology (AOCNMB 2023), co-sponsored by the Asian-Oceanian Union for Nuclear Medicine (AOFNMB), the Arab Society for Nuclear Medicine, the Jordanian Society for Nuclear Medicine and the Asian-Oceanian Academy of Nuclear Medicine, opened in Amman, Jordan.

Policy interpretation | Large medical device configuration License Management Directory (2023) Policy interpretation

In order to thoroughly implement the spirit of the important instructions and instructions of the General Secretary on health work and the decision-making and deployment of the Party Central Committee and The State Council, based on the new development stage of health and health undertakings, further implement the reform requirements of "decentralization and management service"

Industry information | The second offline practical training course for Medical Physicists (Nuclear Medicine) was successfully held

From September 15 to September 17, 2023, the Medical Physicist (Nuclear medicine) training base was jointly built by the Nuclear Medicine Branch of China National Health Association, the Training Department of China National Health Association, the Nuclear Science and Technology College of the University of South China, Jiaxing First Hospital and Zhejiang Ruipai Medical Technology Co., LTD. The second offline practical training course for Medical Physicists (Nuclear Medicine) was successfully held in Jiaxing, Zhejiang Province.

National Health Commission: to correct the problems such as the withdrawal of lecture fees, and vigorously support normal medical activities

The timeline of this medical anti-corruption is relatively clear, the policy line/document line is not completely consistent with the timeline, and the landing is also different in each key link; Simply sort out the relevant information of this medical anti-corruption;

The National Health Commission s reply letter to Member Li Sijins Proposal on benchmarking international Standards and Experience to Accelerate the development of nuclear Medicine and Benefit People

The Commission attaches great importance to nuclear medicine diagnosis and treatment, and on the basis of implementing the regulations and regulations such as the Measures for the Management of Radioactive Drugs and the Regulations on the Management of Radiological Diagnosis and Treatment, it constantly improves relevant policies and measures, and guides local governments to strengthen the construction of nuclear medicine in medical institutions.

Department of Radiation Source Safety Supervision, Ministry of Ecology and Environment: Reply to Consultation on relevant Provisions of Nuclear Medicine Standards

[Editor's note] This is the Ministry of Ecology and Environment's response to the Chinese Society for Radiation Protection's "Request for Consultation on relevant provisions of Nuclear Medicine Standards".

【 Guide 】 31.86 million people! The world s first nuclide treatment guidelines were successfully released in Qingdao!

On August 27, sponsored by the Chinese Anti-Cancer Association and hosted by the Chinese Institute of Integrative Medicine Development Strategy, the Tumor Nuclear Medicine Committee of the Chinese Anti-Cancer Association, and the Affiliated Hospital of Qingdao University, the intensive reading tour activity of "Chinese Tumor Integrated Diagnosis and Treatment Technical Guidelines (CACA) - Nuclide Therapy" was successfully held in Qingdao, Shandong Province.

【 Guangming Daily 】 New breakthrough! Team Wang Fans has developed the world s first broad-spectrum tumor imaging agent for SPECT/CT imaging diagnosis in nuclear medicine

At present, cancer has become a serious threat to people's life and health. According to the latest statistics released by the National Cancer Center, at present, there are about 4.06 million new cancer cases in China every year, and about 2.41 million cancer deaths every year, which is equivalent to about 8 people will get cancer every minute.